申请人:President and Fellows of Harvard College
公开号:US11191773B2
公开(公告)日:2021-12-07
This invention features new compositions and methods that are useful in treating a host with a Gram-negative bacterial infection. Combination therapies comprising an aminocoumarin compound and a polymyxin compound are disclosed, including certain combinations that exhibit synergistic effects. Furthermore, aminocoumarin compounds are described having altered inhibition of DNA gyrase in Gram-negative bacteria and/or the ability to target the transport proteins responsible for assembling lipopolysaccharide in the outer membrane of Gram-negative bacteria.
本发明的特点是采用了新的组合物和方法,可用于治疗患有革兰氏阴性细菌感染的宿主。本发明公开了由氨基香豆素化合物和多粘菌素化合物组成的组合疗法,包括某些表现出协同效应的组合。此外,还描述了氨基香豆素化合物对革兰氏阴性细菌DNA回旋酶的抑制作用发生改变,和/或能够靶向负责在革兰氏阴性细菌外膜中组装脂多糖的转运蛋白。